We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

22 hedge funds and large institutions have $8.86M invested in ImmuCell in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.92% less ownership

Funds ownership: 23.04% → 22.12% (-0.92%)

4% less funds holding

Funds holding: 23 → 22 (-1)

18% less capital invested

Capital invested by funds: $10.8M → $8.86M (-$1.94M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$24K
2
Morgan Stanley
Morgan Stanley
New York
+$10.8K
3
UBS Group
UBS Group
Switzerland
+$8.96K
4
Victory Capital Management
Victory Capital Management
Texas
+$6.3K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.54K

Top Sellers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
-$144K
2
WC
Wexford Capital
Florida
-$144K
3
EVC
Eidelman Virant Capital
Missouri
-$91K
4
PCM
Perritt Capital Management
Illinois
-$58.5K
5
Wells Fargo
Wells Fargo
California
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$3.79M – – –
HA
2
Heartland Advisors
Wisconsin
$975K -$144K -24,600 -12%
PCM
3
Perritt Capital Management
Illinois
$668K -$58.5K -10,000 -8%
AC
4
Antara Capital
New York
$582K – – –
ISL
5
Ingalls & Snyder LLC
New York
$536K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$535K +$24K +4,100 +4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$525K +$3.67K +627 +0.7%
WC
8
Wexford Capital
Florida
$364K -$144K -24,574 -27%
SRC
9
Shufro Rose & Co
New York
$282K – – –
HPC
10
HM Payson & Co
Maine
$147K -$11.7K -2,000 -7%
EFS
11
Essex Financial Services
Connecticut
$120K +$3.51K +600 +3%
Morgan Stanley
12
Morgan Stanley
New York
$84K +$10.8K +1,841 +14%
MA
13
Minerva Advisors
Pennsylvania
$77K – – –
RC
14
RBF Capital
California
$73K – – –
UBS Group
15
UBS Group
Switzerland
$38K +$8.96K +1,533 +29%
Bank of America
16
Bank of America
North Carolina
$17K -$158 -27 -0.9%
FHA
17
Flagship Harbor Advisors
Massachusetts
$16K – – –
BlackRock
18
BlackRock
New York
$10K – – –
Victory Capital Management
19
Victory Capital Management
Texas
$6K +$6.3K +1,077 New
Citigroup
20
Citigroup
New York
$5K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$5K +$4.54K +777 +1,295%
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
EVC
23
Eidelman Virant Capital
Missouri
– -$91K -14,000 Closed
Wells Fargo
24
Wells Fargo
California
– -$13K -1,950 Closed

ICCC Hedge Fund Activity: Q3 2019 in Review

22 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2019, worth a combined $8.86M — down 18% from $10.8M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $24K. The largest seller was Heartland Advisors, cutting an estimated $144K.

  • 22 institutional investors held ImmuCell (ICCC) as of Q3 2019, down from 23 in Q2 2019.
  • Funds reported $8.86M of ImmuCell stock for Q3 2019, down 18% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q3 2019 and 2 closed out, a net change of -1 holder.
  • The largest ImmuCell buyer in Q3 2019 was Renaissance Technologies, an estimated $24K added.
  • The largest ImmuCell seller in Q3 2019 was Heartland Advisors, an estimated $144K sold.

Based on aggregated 13F filings for Q3 2019.